Antibody Therapy Targeting Cancer-Specific Cell Surface Antigen AGR2
For anterior gradient 2 (AGR2), normal cells express the intracellular form iAGR2 localized to the endoplasmic reticulum while cancer cells express the extracellular form eAGR2 localized on the cell surface and secreted. Antibodies targeting eAGR2+ cancer cells for eradication will spare normal cell...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/75838 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Antibody Therapy Targeting Cancer-Specific Cell Surface Antigen AGR2
- Antigen-specific Antibody Multi-modal Foundation Model for Functional Antibody Design
- Antibody-Antigen Binding Events: The Effects of Antibody Orientation and Antigen Properties on the Immunoassay Sensitivity
- Targeted Cancer Therapy Using Nanoparticles and Antibody Fragments
- AbICL: In-Context Learning for Antigen-Specific Antibody Affinity Ranking
- Prostate Specific Membrane Antigen as Biomarker and Therapeutic Target for Prostate Cancer
- Antigen-Specific Antibody Design via Direct Energy-based Preference Optimization